FDA warned Naternal that its CBD oils, gummies, and pet hemp oil are unapproved drugs due to drug claims.
What happened
FDA reviewed www.naternal.com in August 2024 and found products represented to contain CBD, CBG, and CBN, with website claims that they treat conditions such as high blood pressure, Alzheimer's, PTSD, autism, cancer, glaucoma, and opioid addiction. FDA also found pet hemp oil claims and customer-review replies about seizures, arthritis, and diabetes in pets. FDA determined the human products are unapproved new drugs and the pet products are unapproved new animal drugs.
What FDA found
The CBD oil and gummy products were marketed with claims to treat diseases and affect body functions, making them drugs, but they have no FDA-approved application.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)FDA treats the products as new drugs because they are not generally recognized as safe and effective for the claimed uses.
FD&C Act section 201(p), 21 U.S.C. 321(p)The pet hemp extract oils were marketed to treat seizures, arthritis, and diabetes in animals, but FDA says they are not approved or legally listed and are therefore unsafe under the animal drug law.
FD&C Act sections 512(a), 501(a)(5), and 301(a), 21 U.S.C. 360b(a), 351(a)(5), and 331(a)Website customer reviews and company replies were used as evidence that the pet products were intended to treat animal diseases.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)The company marketed CBD products for opioid addiction treatment, an unproven use that FDA says could cause patients to delay or forgo approved treatment.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
What FDA wants
FDA asks the company to notify it in writing within 15 working days of the specific steps taken to correct the violations, prevent recurrence, and provide related documentation. If corrective action cannot be completed in that time, the company must state why and give a completion date, sending the response to FDAADVISORY@fda.hhs.gov.
Who should pay attention
- CBD and hemp product brands that make health claims online
- retailers and marketplaces selling CBD/hemp supplements
- pet supplement sellers and veterinarians advising pet owners
This is a summary. Read the original letter on fda.gov.